{"url_path":"/sec/jbio/8-k/2026-06-11/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-11","source_url":"https://www.sec.gov/Archives/edgar/data/1798749/0001193125-26-267640-index.html","accession_number":"0001193125-26-267640","cik":"0001798749","ticker":"JBIO","issuer_name":"Jade Biosciences, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1798749/0001193125-26-267640-index.html","primary_entity_key":"0001798749","primary_entity_name":"Jade Biosciences, Inc."},"word_count":107,"has_tables":true,"body_markdown":"Item 9.01\n\nFinancial Statements and Exhibits.\n\n(d) Exhibits\n\n \n\nExhibit\n\nNumber\n\n  \nDescription\n\n 3.1\n  \n[Amended and Restated Articles of Incorporation](d161530dex31.htm)\n\n 3.2\n  \n[Amended and Restated Bylaws, effective as of June 9, 2026 (clean version)](d161530dex32.htm)\n\n 3.3\n  \n[Amended and Restated Bylaws, effective as of June 9, 2026 (marked version)](d161530dex33.htm)\n\n104\n  \nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n \nJADE BIOSCIENCES, INC.\n\nDate: June 11, 2026\n \n\n \nBy:\n \n\n/s/ Bradford Dahms\n\n \n\n \nName:\n \nBradford Dahms\n\n \n\n \nTitle:\n \nChief Financial Officer and Treasurer"}